The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
CSPC will receive an upfront payment of $100 million from AstraZeneca
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
The inspection was concluded with zero observations
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Dyslipidemia is a critical risk factor for cardiovascular diseases
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
Subscribe To Our Newsletter & Stay Updated
